Nutricircle Ltd to Review Q2 FY27 Results on November 14

Nutricircle Ltd will consider its Q2 FY27 unaudited financial results on 14 November 2026, following Q1 FY27 revenue of ₹5.50 crore, up 151% year on year. The board meeting will also consider the limited review report for the quarter and half-year ended 30 September 2026.

When will Nutricircle Ltd announce its Q2 FY27 results?

Nutricircle Ltd has scheduled a board meeting for Saturday, 14 November 2026, to consider and approve unaudited financial results for the quarter and half-year ended 30 September 2026. The company has stated that the meeting will consider the related limited review report along with the financial statements.

The scheduled disclosure is important because it will provide the first reported half-year performance update for FY27. The company had previously indicated that the board meeting to approve these results would be held on or before 14 November 2026. The results are expected to cover the three months ended 30 September as well as the six-month period beginning 1 April 2026.

The announcement follows the company’s Q1 FY27 results, which were approved by the board on 14 August 2026. Those standalone results showed a sharp rise in revenue from operations compared with the corresponding quarter of the previous financial year.

What does the trading-window closure mean for investors?

Nutricircle Ltd closed its trading window for designated persons from 1 October 2026 until 48 hours after the announcement of the unaudited results. This restriction applies to dealing in the company’s securities by persons covered under its insider-trading compliance framework.

The closure is linked to the preparation and release of unpublished price-sensitive information, including quarterly financial statements. It does not prevent public shareholders from trading, but it limits transactions by designated insiders and connected persons during the specified period.

For investors, the relevant next disclosure is the outcome of the 14 November board meeting. That filing should establish the reported revenue, profitability and other financial line items for Q2 FY27 and the first half of the financial year. The supplied information does not provide a Q2 earnings estimate or management guidance.

How did Nutricircle Ltd perform in Q1 FY27?

Nutricircle Ltd reported Q1 FY27 revenue from operations of ₹5.50 crore, compared with ₹2.19 crore in Q1 FY26 and ₹4.88 crore in Q4 FY26. The year-on-year increase was approximately 151%, while sequential revenue growth was 12.7% from the March 2026 quarter.

Net profit after tax for Q1 FY27 was ₹0.04 crore, compared with ₹0.03 crore in both Q4 FY26 and Q1 FY26. While profit increased from the year-earlier quarter, the reported profit margin was 0.7%, lower than 1.4% in Q1 FY26. The company attributed the margin decline to higher expenses.

The Q1 result provides the immediate base for assessing the September-quarter disclosure. Revenue growth was much faster than the increase in post-tax profit, making cost levels and margins relevant items to review when the Q2 numbers are released. No Q2 revenue, profit or margin data were included in the available announcement.

What background is relevant before the September-quarter update?

Nutricircle Ltd was previously known as Shreyash Industries Limited. Its Q1 FY27 standalone results were prepared under Indian Accounting Standards prescribed under Section 133 of the Companies Act, 2013, and were reviewed by the Audit Committee before approval by the board.

The company also disclosed a memorandum of understanding with the Institute of Chemical Technology, Mumbai, entered into on 24 July 2026. The supplied disclosure does not state the financial terms, commercial scope or expected revenue contribution from this memorandum. Investors therefore cannot quantify its effect on FY27 results from the available information.

Older quarterly information in the supplied material shows that Nutricircle Ltd had a different revenue and earnings profile in earlier periods. For the quarter ended March 2016, the company reported total income of ₹1.85 crore and a reported loss of ₹0.43 crore. Such historical data are not directly comparable with the current period, but they provide context for the reported rise in Q1 FY27 revenue.

How could the Q2 FY27 disclosure affect investor assessment?

The Q2 FY27 release will give investors a clearer view of whether the Q1 revenue momentum continued into the September quarter. The central data points will be revenue from operations, profit after tax, expense movement and the margin trend, particularly after Q1 profitability grew more slowly than revenue.

The half-year results will also allow comparison of the first six months of FY27 with the company’s reported FY26 revenue of ₹17.77 crore. However, the available information does not provide an FY27 revenue target, a capital-expenditure programme, capacity-expansion plan or earnings outlook. Any assessment of full-year performance would therefore need to wait for reported financial data and further company disclosures.

The board meeting itself does not confirm an operational change or a financial outcome. Its immediate relevance is as the formal route through which Nutricircle Ltd will place its September-quarter and half-year financial information before investors, along with the limited review report.

Conclusion

Nutricircle Ltd is due to consider Q2 FY27 unaudited standalone results and the limited review report on 14 November 2026. The update follows Q1 FY27 revenue of ₹5.50 crore, up 151% year on year, alongside a 0.7% profit margin that was below the corresponding prior-year quarter.

Investors should watch the board-meeting outcome for Q2 and half-year revenue, costs, profitability and any further detail on operations or outlook. The trading window will remain closed for designated persons until 48 hours after the unaudited results are announced.